Tumor tissue

OTHER7 trials

Conditions

Advanced CancersAdvanced Digestive CancerAdvanced Gynecologic CancerAnaplastic AstrocytomaAnaplastic Pleomorphic XanthoastrocytomaBRAF V600EBRAF V600KBreast Cancer

Phase 1

MCS110 Combined With Neoadjuvant Doxorubicin, Cyclophosphamide, and Weekly Paclitaxel in Patients With Hormone-Receptor Positive and HER2- Breast Cancer

WithdrawnNCT03285607

Washington University School of MedicineBreast Cancer, Cancer of Breast

Start: 2018-09-30End: 2021-02-28Updated: 2018-08-16

Phase 2

Study of Binimetinib With Encorafenib in Adults With Recurrent BRAF V600-Mutated HGG

TerminatedNCT03973918

Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsAnaplastic Astrocytoma, Anaplastic Pleomorphic Xanthoastrocytoma, BRAF V600E +4

Start: 2019-07-29End: 2023-10-01Updated: 2024-10-31

Unknown Phase

Genomic Profiling Assay in Phase I

CompletedNCT02437617

M.D. Anderson Cancer CenterAdvanced Cancers

Start: 2012-07-13End: 2021-06-01Updated: 2021-06-14

Biobank for African American Prostate Cancer Research in Florida

CompletedNCT03232411

H. Lee Moffitt Cancer Center and Research InstituteProstate Cancer

Start: 2017-03-22End: 2024-01-23Updated: 2025-12-04

Exploratory Study of the Relevance of a Blood Test in the Management of Patients in the Context of Colorectal Cancer Screening

RecruitingNCT04767568

Centre Hospitalier Universitaire de BesanconColorectal Cancer

Start: 2021-03-30End: 2032-08-01Target: 400Updated: 2026-03-16

Identification of a MOLecuLar Signature in Locally Advanced Cervical Cancer Patients

NCT06016868

Fondazione Policlinico Universitario Agostino Gemelli IRCCSCervical Cancer

Start: 2023-08-01End: 2025-08-01Target: 25Updated: 2023-08-30

Identification of Innovative Biomarkers Related to the Immune System or Tumor Microenvironment to Promote the Efficacy of Immunotherapies

RecruitingNCT06626269

Centre Hospitalier Universitaire de BesanconAdvanced Digestive Cancer, Advanced Gynecologic Cancer

Start: 2025-02-10End: 2032-02-29Target: 700Updated: 2025-06-20

Related Papers

Response Rate and Molecular Correlates to Encorafenib and Binimetinib in BRAF-V600E Mutant High-Grade Glioma

Clinical Cancer Research2024-03-0615 citations

CTNI-60. PRELIMINARY RESULTS OF BINIMETINIB AND ENCORAFENIB IN ADULTS WITH RECURRENT BRAF V600E-MUTATED HIGH-GRADE GLIOMA